CHRISTIANSON MARK (Business Development Director) reported 1 transaction at NEUROONE MEDICAL TECHNOLOGIES CORP
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2025ACC: 0001709738-25-000008
Officer· Business Development Director
Since Feb 2026
-253.00
Net shares
Net seller
$171.53
Total sold
0
Open market trades
0B · 0S
1
Total transactions
253.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−253.00
Price / share
$0.68
Trade value
$171.53
% of position
0.1%
6/30/2025
261.49K→261.24K
Total
Net shares
−253.00
Net value
-$171.53
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | F · Tax Withholding | −253.00 | $0.68 | $171.53 | 0.1% | 261.49K | 261.24K |
| Total | −253.00 | -$171.53 | ||||||
Derivative Transactions0
No derivative transactions reported